OGDEN MANUFACTURING PLANT OPTIFLUX 180NRE DIALYZER FINISHED ASSY.; DIALYZER, HIGH PERMEABILITY WITH OR WITHOUT SEALED DIALYSATE SYSTEM
|
Back to Search Results |
|
Model Number 0500318E |
Device Problem
Fluid/Blood Leak (1250)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 10/21/2022 |
Event Type
malfunction
|
Event Description
|
A user facility biomedical technician (bmt) reported that a blood leak occurred immediately after the start of the patient¿s hemodialysis (hd) treatment.The bmt confirmed that the machine, a fresenius 2008t machine, alarmed appropriately with a "minor" blood leak alarm and treatment was immediately discontinued.Blood leak test strips were used and tested negative for the presence of blood.The bmt also stated that fresenius bloodlines were used for treatment and confirmed that the leak was internal and no external blood leak was observed.The bmt stated that there were no defects or damage seen on the dialyzer.Per bmt the patient¿s blood was not returned and stated the estimated blood loss was 250 ml.Immediately following the event, the patient was re-setup with new supplies on the same machine where the patient was able to complete treatment.The bmt confirmed that there was no patient injury, adverse events, or medical intervention required as a result of the reported event.The dialyzer was available to be returned for manufacturer evaluation.
|
|
Manufacturer Narrative
|
Plant investigation: the plant investigation is in process.A supplemental mdr will be submitted upon completion of this activity.
|
|
Event Description
|
A user facility biomedical technician (bmt) reported that an external dialyzer blood leak occurred immediately after the start of the patient¿s hemodialysis (hd) treatment.The bmt confirmed that the machine, a fresenius 2008t machine, alarmed appropriately with a "minor" blood leak alarm and treatment was immediately discontinued.Blood leak test strips were used and tested negative for the presence of blood.The bmt also stated that fresenius bloodlines were used for treatment and confirmed that a cracked header was observed on the dialyzer.Per bmt the patient¿s blood was not returned and stated the estimated blood loss was 250 ml.Immediately following the event, the patient was re-setup with new supplies on the same machine where the patient was able to complete treatment.The bmt confirmed that there was no patient injury, adverse events, or medical intervention required as a result of the reported event.The dialyzer was available to be returned for manufacturer evaluation.
|
|
Manufacturer Narrative
|
Additional information: b5, h6.
|
|
Manufacturer Narrative
|
Plant investigation: a sample from the reported lot was returned for evaluation.During the visual examination of the sample, the cavity id end header cap of the dialyzer was observed to have cracks.Cracks were found all the way around the header.No other damage or irregularities were noted on the returned sample.During the lot history review it was noted that there were no other complaints of any kind reported against the lot.A production records review was performed on the reported lot.An investigation of the device history records (dhr) was conducted by the manufacturer.There was no indication of product nonacceptance, deviation, non-conformance, rework, labeling or process control failure during the manufacturing process which could be associated with the reported event.The lot met all release criteria.The investigation into the complaint was able to confirm the reported event.This includes non-conformances, rework, labeling, process controls, and any other occurrence in production that was potentially related to the complaint.The reported lot number passed pyrogen testing, was within sterilization dosage parameters and passed all release criteria.Continuous improvement is of the utmost importance to fresenius medical care as we strive to provide dialysis products of the highest quality to our patients.Reports of leaking product are investigated both individually as complaints, as well as via the nc/capa program, in order to assess and improve our products and processes.Capas 2018-0171 (vision systems) and 1141369 (blood leak reduction) are recent examples of leak related investigations directed at an overall reduction in dialyzer leaks.
|
|
Event Description
|
A user facility biomedical technician (bmt) reported that an external dialyzer blood leak occurred immediately after the start of the patient¿s hemodialysis (hd) treatment.The bmt confirmed that the machine, a fresenius 2008t machine, alarmed appropriately with a "minor" blood leak alarm and treatment was immediately discontinued.Blood leak test strips were used and tested negative for the presence of blood.The bmt also stated that fresenius bloodlines were used for treatment and confirmed that a cracked header was observed on the dialyzer.Per bmt the patient¿s blood was not returned and stated the estimated blood loss was 250 ml.Immediately following the event, the patient was re-setup with new supplies on the same machine where the patient was able to complete treatment.The bmt confirmed that there was no patient injury, adverse events, or medical intervention required as a result of the reported event.The dialyzer was available to be returned for manufacturer evaluation.
|
|
Search Alerts/Recalls
|
|
|